Replimune Group (REPL): Goldman Sachs units disclose 5.3% beneficial stake
Rhea-AI Filing Summary
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC report beneficial ownership of 4,418,837.86 shares of Replimune Group Inc. common stock, representing 5.3% of the class. All voting and dispositive authority is reported as shared, with no sole voting or dispositive power.
The position is held through Goldman Sachs & Co. LLC, a broker-dealer and registered investment adviser and a subsidiary of The Goldman Sachs Group, Inc. The reporting units within Goldman Sachs disclaim beneficial ownership for certain client accounts and investment entities where third parties hold economic interests.
Positive
- None.
Negative
- None.
Key Figures
Beneficially owned shares: 4,418,837.86 shares
Percent of class: 5.3%
Shared voting power: 4,418,789.86 shares
+3 more
6 metrics
Beneficially owned shares
4,418,837.86 shares
Replimune Group Inc common stock reported by Goldman Sachs entities
Percent of class
5.3%
Portion of Replimune Group Inc common stock beneficially owned
Shared voting power
4,418,789.86 shares
Shares over which Goldman Sachs reports shared power to vote
Shared dispositive power
4,418,837.86 shares
Shares over which Goldman Sachs reports shared power to dispose
CUSIP
76029N106
CUSIP for Replimune Group Inc common stock, par value $0.001
Maturity or reference date
06/30/2026
Dated reference associated with the reported Replimune securities
Key Terms
beneficial ownership, shared voting power, shared dispositive power, parent holding company, +2 more
6 terms
beneficial ownership financial
"The securities being reported on by The Goldman Sachs Group, Inc. are owned, or may be deemed to be beneficially owned"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
parent holding company financial
"The securities being reported on by The Goldman Sachs Group, Inc. ("GS Group"), as a parent holding company"
broker or dealer financial
"Goldman Sachs & Co. LLC ("Goldman Sachs"), a broker or dealer registered under Section 15 of the Act"
A broker or dealer is a financial middleman who helps people buy and sell securities: a broker acts like a matchmaker who executes trades on behalf of a client, while a dealer buys and sells from their own inventory like a shopkeeper. Investors care because these roles affect trade prices, fees, execution speed and potential conflicts of interest—similar to choosing between a personal shopper and a retailer, which can change what you pay and how reliably you get what you want.
investment adviser financial
"an investment adviser registered under Section 203 of the Investment Advisers Act of 1940"
An investment adviser is a person or firm that professionally manages money and gives recommendations about buying, selling, or holding investments. Like a financial coach or guide, they have a legal duty to act in a client's best financial interest, so their advice, fees and potential conflicts can directly affect returns and risk — making their role important for investors who want informed, accountable help with portfolios.
FAQ
What stake in Replimune Group Inc (REPL) does Goldman Sachs report?
Goldman Sachs reports beneficial ownership of 4,418,837.86 shares of Replimune Group Inc common stock, representing 5.3% of the outstanding class, with the position reported on a shared voting and dispositive basis.
Which Goldman Sachs entities are reporting ownership in REPL?
The reporting entities are The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC. The shares are owned or deemed beneficially owned by Goldman Sachs & Co. LLC, with The Goldman Sachs Group, Inc. filing as a parent holding company.
What percentage of Replimune Group Inc (REPL) does Goldman Sachs’ position represent?
The reported Replimune Group Inc holding represents 5.3% of the outstanding common stock. This percentage is based on the class of common shares with par value $0.001 per share identified in the ownership report.
Does Goldman Sachs claim full beneficial ownership of its REPL holdings?
Goldman Sachs’ reporting units disclaim beneficial ownership of securities held for certain client accounts and investment entities where third parties hold interests, even though those positions may be aggregated for reporting under beneficial ownership rules.
AI-generated analysis. How Rhea-AI works. Not financial advice.